MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells
Taxanes are chemotherapeutic agents used in the treatment of solid tumors, particularly of breast, ovarian, and lung origin. However, patients show divergent therapy responses, and the molecular determinants of taxane sensitivity have remained elusive. Especially the signaling pathways that promote...
Main Authors: | Sofia Aakko, Anne Hege Straume, Einar Elvbakken Birkeland, Ping Chen, Xi Qiao, Per Eystein' 'Lønning, Marko J. Kallio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318304820 |
Similar Items
-
MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
by: Thomas Greither, et al.
Published: (2020-08-01) -
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
by: Nina Dusílková, et al.
Published: (2017-10-01) -
The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
by: Cláudia Regina Gasque Schoof, et al.
Published: (2015-01-01) -
Methylation of <it>miR-34a, miR-34b/c</it>, <it>miR-124-1 </it>and <it>miR-203 </it>in Ph-negative myeloproliferative neoplasms
by: Chim Chor Sang, et al.
Published: (2011-11-01) -
Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value
by: Sarah Atef Fahim, et al.
Published: (2020-07-01)